The Guidelines for the Diagnosis and Treatment of Malignant Pleural Mesothelioma are the result of a systematic review of the literature guided by National Health and Medical Research Council (NHMRC) methodology. Recommendations for the management of this asbestos-related malignancy have been made on the basis of the available scientific evidence.

The Asbestos Diseases Research Institute, and the national team of experts involved in the preparation of the Guidelines intend that they be a source of reference for health practitioners and consumers. Guidelines are guides and not rules. A good approach is to be fully aware of appropriate guidelines before making management decisions.

These Guidelines will assist health practitioners: 
• To make adequate steps in the diagnostic process, and
• To identify the prerequisites needed to draft an optimal treatment proposal.

These guidelines were approved by the Chief Executive Officer of the NHMRC on 2 July 2013, under Section 14A of the National Health and Medical Research Council Act 1992. In approving these guidelines the NHMRC considers that they meet the NHMRC standard for clinical practice guidelines. This approval is valid for a period of 5 years.

The development of these Guidelines was made possible by a generous donation from the Biaggio Signorelli Asbestos Foundation; a Cancer Institute NSW grant and a contribution from Cancer Council NSW.


DOWNLOAD Guidelines for the diagnosis and treatment of malignant pleural mesothelioma (PDF 1.2 MB)


See also: